xFOREST Therapeutics Co., Ltd. ("xFOREST") and Axcelead Drug Discovery Partners, Inc. ("Axcelead DDP") today announced the launch of a joint research collaboration aimed at developing RNA ...

Human papillomaviruses, or HPVs, can cause dangerous infections in the skin and mucous membranes and may lead to cancer. Vaccines that prevent mucosal HPV infections aren't effective against cutaneous ...

Share on Pinterest Researchers say a molecule-based drug could prove to be a new treatment for multiple sclerosis. Bloomberg Creative/Getty Images Researchers are reporting they have looked at the ...

This is a preview. Log in through your library . Abstract Background. Small-molecule CD4-mimetic compounds (CD4mc) inhibit human immunodeficiency virus (HIV-1) entry by blocking binding to the CD4 ...

Researchers have identified a small molecule that could lead to a safe and effective treatment for the neurodevelopmental condition known as Angelman syndrome. Angelman syndrome is a rare genetic ...

Researchers have revealed a previously unknown way plants shape their growth in response to light—a breakthrough that could better equip crops to handle environmental stress.

Angelman syndrome is a rare genetic disorder caused by mutations in the maternally-inherited UBE3A gene and characterized by poor muscle control, limited speech, epilepsy, and intellectual ...

A novel compound strongly improves the efficacy of naloxone, the substance used to reverse overdoses of morphine, fentanyl and other opioid drugs. When administered to mice along with naloxone, it is ...

“There is an urgent need to develop non-addictive treatments for chronic pain," says Susruta Majumdar, Ph.D of Washington University School. Approximately 125 million opioid prescriptions were ...

The financing will see NRG5051 into clinical trials. Miller says Phase 1 could start as early as December. The firm is also ...